Evaluation of New Screening Technologies

New technologies for breast cancer screening are rapidly diffusing into community practice. Digital mammography and Computer Aided Detection (CAD) have become widespread. MRI is now recommended as an adjunct to mammography for women at high risk of developing breast cancer. Three-dimensional digital tomosynthesis mammography is also becoming available at some breast imaging facilities. While many of these technologies have been evaluated in randomized trials, the performance of these imaging tools in community practice settings in women with diverse risk characteristics is currently unclear.

With the Breast Cancer Surveillance Consortium, we are seeking to:

  • Evaluate the performance of advanced imaging technologies
  • Determine patient subgroups for whom advanced imaging technologies are most appropriate